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Abstract  
Introduction: Symptoms of sepsis are non-specific among neonates and diagnosis requires a high index of suspicion. The study sought to 
evaluate the utility of procalcitonin (PCT) versus C-reactive protein (CRP) in diagnosing early-onset neonatal sepsis. Methods: This was a cross-
sectional study in which neonates admitted to the neonatal intensive care unit, with signs suggesting sepsis were categorized according to an 
adapted criteria from Tollner's sepsis score and case definition of bloodstream infection as: ''highly probable'', ''probable'' and ''less probable''. 
Laboratory investigations including blood culture, complete blood count, PCT and CRP levels were done before first antimicrobial drug 
administration. Results: A total of 62 neonates less than 12 hours postnatal age (0.16-9.82 hours) were recruited. Proportion of neonates with 
PCT>2 ng/mL was 91% (20/22) in the ''highly probable'' group compared to 31.6% (6/19) in the ''probable group'' (p<0.001). Neonates with 
CRP>5 mg/L was 54.4% (12/22) in the ''highly probable'' group compared to 26.3% (5/19) in the ''probable group'' (p = 0.07). The receiver 
operator characteristics for PCT and CRP were; sensitivity (87.5% vrs 50%), specificity (63.0% vrs 72.2%), positive predictive value (44.1% vrs 
37.5%) and negative predictive value (93.8% vrs 81.3%), respectively. Conclusion: PCT was a better predictive marker for neonatal sepsis within 
the first 12 hours of life than CRP in this setting, however, its low specificity relative to CRP suggests that neonates without patent infection are 
more likely to be incorrectly diagnosed with sepsis using this test. 
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Introduction 
 
Neonatal sepsis represents an important cause of morbidity and 
mortality especially in low-resource settings. Early diagnosis and 
prompt treatment of neonatal sepsis improves outcome [1]. 
However, the diagnosis of neonatal sepsis is complicated by many 
factors, including the non-specific clinical symptomatology and 
absence of specific biomarkers for diagnosis. Although blood culture 
remains the gold standard for diagnosis, the high false negative rate 
[2] and delay in obtaining results, places limitations on its clinical 
utility, thus the need for additional methods and continuous 
validation for existing markers in neonatal populations. C-reactive 
protein (CRP), an acute-phase reactant of hepatic origin that 
increases following secretion of interlukin-6 from macrophages and 
T-cells [3, 4], is elevated in acute inflammatory conditions, including 
infection. CRP is a valuable screening marker for the diagnosis of 
neonatal sepsis [5, 6], however, the time needed for its release, the 
non-specific response to inflammation, as well as variations in levels 
depending on physiological state (e.g birth weight or gestational 
age) [7-10], exerts a limitation on the use of CRP as a marker for 
neonatal sepsis diagnosis. Furthermore, CRP level has been shown 
to be low or normal in infants infected with coagulase-negative 
staphylococcus [11] and the magnitude of the CRP response is 
known overall to be higher in Gram-negative compared to Gram-
positive infections [7]. 
  
Procalcitonin (PCT), a pro-hormone of calcitonin, synthesized by 
thyroid C cells [12] and which level increases markedly in septic 
conditions [13], is considered by some as a more sensitive marker 
than CRP in the early identification of bacterial infection in neonates 
[14, 15]. After exposure to bacterial agents, PCT levels increase 
within 3-4 hours, while CRP levels increase 12-18 hours later [16]. 
However, the role of these two markers in diagnosis of neonatal 
sepsis remain contentious [17, 18]: procalcitonin levels have been 
shown to vary between preterm and late-preterm neonates [19-21]. 
In term neonates, PCT demonstrates age-specific variation between 
the time of birth up to 48 hours [22], suggesting that cut-off levels 
of this acute-phase reactant should be age-dependent. Nonetheless, 
the features of physiological changes and reference in various infant 
populations have not been extensively studied. The incidence of 
early-onset neonatal sepsis vary between countries and study 
centers [23]. Also, depending on etiological agents, Gram-positive 
or Gram-negative bacteria, inflammatory response to infection could 
vary [24]. The heterogeneity of responses as well as difficulties in 
adopting a uniform definition for neonatal sepsis underlines the 
need to generate data from different settings in determining cut-off 
values of acute-phase reactants in the diagnosis of neonatal sepsis. 
Early-onset neonatal sepsis is commonly associated with co-morbid 
conditions but studies conducted to evaluate diagnostic utility of 
CRP and/or PCT rarely exclude confounders like perinatal asphyxia 
or meconium aspiration, which could affect predictive accuracy [25-
27]. This study investigated the utility of CRP and PCT in neonates 
with suspected sepsis, excluding possible confounders and 
compared levels of these acute-phase reactants with clinical data 
and blood culture results. 
  
  
Methods 
 
Study design and site: This was a cross-sectional study, a sub-
component of a larger study that evaluated the disposition of 
amikacin in neonates with suspected sepsis at the Neonatal 
Intensive Care Unit (NICU), Korle-Bu Teaching Hospital, Accra, 
Ghana, from November 2013 to June 2014. The full details of the 
larger study has been reported elsewhere [28]. The NICU is a 55-
bed tertiary unit that admits annually an average of 2000 sick and 
preterm neonates mainly from southern Ghana. The NICU restricts 
admission to neonates with postnatal age less than 48 hours, unless 
in exceptional situations. 
  
Criteria for inclusion and exclusion: Admitted neonates that 
fulfilled criteria (described below) were purposely selected. Eligible 
neonates were categorized as; ''highly probable'', ''probable'' and 
''less probable'' neonatal sepsis, based on an adapted criteria from 
Tollner's sepsis score [29] and case definition of bloodstream 
infection by Vergnano et al [30] (Table 1). 
  
Inclusion: neonates with maternal risk factors (prolonged rupture of 
amniotic membrane >18 hrs, chorioamnionitis), neonatal risk factors 
(low birth weight and premature birth) and clinical symptoms 
(feeding intolerance, lethargy, temperature instability, tachypnea, 
bradycardia, tachycardia, abdominal distension or vomiting) and 
deemed by the admitting physician to have a presumptive diagnosis 
of sepsis, were enrolled. 
  
Exclusion: neonates presenting with meconium aspiration, perinatal 
asphyxia or neonates who required resuscitation for any reason, 
were excluded. 
  
Blood sampling and laboratory analysis: After initial 
examination by study pediatrician and before first antimicrobial drug 
dose, blood samples were taken from recruited neonates, for the 
following investigations: blood culture (1-2 mL), full blood count 
(0.5 mL), CRP and PCT (0.5 mL). The sample for culture was 
collected into pediatric culture vials (BACTEC Peds plus/F, Becton-
Dickinson, Gauteng, South Africa) and those for full blood count, 
CRP and PCT analysis into EDTA and gel microtainer tubes, 
respectively. The samples for measurement of CRP and PCT levels 
were immediately centrifuged to obtain serum. Blood culture was 
done using a fully automated BACTEC 9240 blood culture system 
(Becton Dickinson Diagnostic Instrument Systems, Sparks, 
Maryland). Isolates from positive bottles were sub-cultivated and 
identified using biochemical methods. Briefly, Gram-positive bacteria 
were identified by catalase, slide and tube coagulase test and Gram-
negative by API 20E and 20NE (BioMerieux, France). Antibiotic 
susceptibility tests were done using the disc diffusion method on 
Mueller-Hinton agar (Oxoid, UK), in accordance with Clinical 
Laboratory Standards Institute (CLSI) criteria. Complete blood count 
was done by means of a Sysmex Autoanalyzer (Sysmex KX-21N, 
Sysmex Corporation, Kobe, Japan). CRP assay was performed with a 
BNII automated system (Dade-Behring Inc, Newark, Delaware), 
according to manufacturer's instructions. The assay uses particle-
enhanced immunonephelometry to quantify CRP in serum samples 
[31]. Limit of detection of assay was 0.17 mg/L. 
Electrochemiluminescence immunoassay, which is based on a 
sandwich principle [32], was used to analyze PCT in serum of 
neonates. An automated Elecsys (Roche Diagnostics, Rotkreuz, 
Switzerland) was used for this purpose according to manufacturer's 
instructions. Limit of detection of assay was 0.1 ng/mL. 
  
Ethical issues: Approval of this research was from the Ethical and 
Protocol Review Committee of the School of Medicine and Dentistry, 
University of Ghana (Protocol ID: MS-Et/M.8-P.5.3/2011-2012). 
Written informed consent was obtained from parents of all recruited 
neonates. 
  
Statistical analysis: One-way ANOVA was used to compare the 
means of selected clinical and laboratory parameters (PCT and CRP 
levels) between the ''highly probable'', ''probable'' and ''less 
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probable'' neonatal sepsis groups. Chi-square was used to compare 
proportions of neonates with elevated PCT and CRP among the 
groups. Blood culture was used as the gold standard for receiver 
operator characteristics (ROC) of PCT and CRP. Area under the ROC 
curve (AUC) for PCT and CRP were compared using Chi-square. A p-
value <0.05 was considered statistically significant. 
  
  
Results 
 
Patient characteristics and outcome: A total of 62 neonates 
fulfilled criteria for inclusion and were categorized as: highly 
probable (22 neonates), probable (19 neonates) and less probable 
(21 neonates) sepsis. All neonates were recruited within 12 hours 
after birth (0.16-9.82 hours) and prior to first antimicrobial drug 
dose. Selected baseline demographic and clinical parameters are 
shown in Table 2. The overall mortality was 9.7% (n=6) and case 
fatality per group was 13.6% (n=3), 10.5% (n=2) and 4.8% (n=1) 
in the highly probable, probable and less probable groups, 
respectively. All neonates who died were less than 34 weeks 
gestational age and weighed less than 1500 grams. 
  
PCT and CRP levels between groups: Mean PCT levels were 
significantly different between the three groups. The PCT levels 
followed the order: ''highly probable'' > ''probable'' > ''less 
probable'' groups (Table 2). Mean CRP levels showed a similar 
trend, however, this difference did not attain statistical significance 
(p = 0.08). The PCT levels were elevated (>2 ng/mL) in 91% 
(20/22) of neonates in the highly probable group compared to 
31.6% (6/19) in the probable group (p<0.001). The proportion of 
neonates with elevated (>5 mg/L) CRP levels was higher in the 
highly probable group (54.5%; 12/22) compared to probable 
(26.3%; 5/19), but the difference (p=0.07) showed only a trend 
towards but did not attain statistical significance. 
  
Positive blood culture and sepsis risk score: In all, 36.4% 
(8/22) of neonates in the ''highly probable'' group had positive blood 
cultures. Among the ''highly probable'' neonatal sepsis risk group, 
there was no statistically significant difference in mean (SD) PCT 
(4.3 (2.4) ng/mL versus 4.1 (0.6) ng/mL; p = 0.9) and CRP (11.3 
(21.7) mg/L versus 5.2 (1.2) mg/L; p = 0.3) between those with 
positive blood cultures and those with negative blood cultures 
respectively. Overall, CRP levels were more reflective of blood 
culture positivity even though the difference was not statistically 
significant. Clinical characteristics, PCT and CRP levels of neonates 
with positive blood culture are shown in Table 3. 
  
Diagnostic accuracy of PCT and CRP: The receiver operator 
characteristic curves (ROCs) of PCT and CRP are shown in Figure 1. 
The area under the receiver operating characteristic curve (AUC) for 
PCT was 0.646 compared to that of 0.569 for CRP (p = 0.09) and 
these were at optimal thresholds of 2 ng/mL and 5 mg/L for PCT 
and CRP, respectively. Using the above thresholds, the sensitivity, 
specificity, positive predictive value (PPV) and negative predictive 
value (NPV) of PCT and CRP were: 87.5% versus 50.0%, 63.0% 
versus 72.2%, 44.1% versus 37.5% and 93.8% versus 81.3%, 
respectively. 
  
  
Discussion 
 
Diagnosis of neonatal sepsis remains a difficult task due to the non-
specific nature of clinical signs and symptoms in this age group. As 
sepsis remains a major cause of neonatal deaths, the standard of 
care includes the use of empiric antibiotic treatment on wide 
indications. As a result, the fear of missing a case of neonatal 
infection invariably leads to an overuse of antibiotics at NICUs. To 
ensure antimicrobial accountability while reducing neonatal deaths, 
there is the need for newer, faster and reliable markers of infection, 
and continuous validation of existing ones. In the current study, the 
proportion of neonates with elevated PCT in the highly probable 
sepsis group was significantly different compared with the probable 
sepsis group. Generally, serum PCT levels begin to rise 4 hours after 
exposure to bacterial endotoxin, peaks at 6-8 hours, and remain 
raised for at least 24 hours [33]. On the other hand, CRP levels start 
to increase 4 to 6 hours later than PCT and reaches peak 36 hours 
later [34]. Thus, the high proportion of neonates in the highly 
probable sepsis group with elevated PCT, relative to CRP, is 
consistent with the kinetics of these biomarkers after exposure to 
bacterial agents [33, 34]. PCT levels greater than 10 ng/mL have 
been associated with high mortality [35], however, the PCT levels of 
all neonates who died in this study were less than 10 ng/mL. A 
possible reason for this observation could be the fact that all 
neonates who died were delivered preterm [36]. 
  
The higher AUC of the ROC curve for PCT compared to that of CRP 
is consistent with studies [37, 38], on early-onset neonatal sepsis. 
In contrast Park et al [39], studied newborns with postnatal age 
ranging between 4 and 30 days and reported a lower AUC (0.803) 
of PCT compared to CRP (0.951). These dissimilarities could be due 
to differences in postnatal age and the kinetics of these biomarkers. 
PCT showed higher sensitivity, PPV and NPV compared to CRP in 
this study. These results, together with others [37, 38, 40], suggest 
that PCT is a more sensitive marker for sepsis diagnosis within the 
first 24 hours of life. The utility of the high NPV of PCT in this study 
may be its potential in excluding neonates without sepsis. This may 
be helpful in decision-making about early discontinuation of 
antibiotics in neonates without strong clinical indicators of sepsis. 
PCT is a relatively more reliable diagnostic marker for diagnosis of 
early-onset neonatal sepsis, the cost of the test precludes its routine 
use in clinical management of sepsis [41]. Therefore, a cost benefit 
analysis is recommended if PCT is to be used as diagnostic marker, 
alone or in combination with others, for sepsis at NICUs, especially 
in low-resource settings. A limitation of this study is the weakness 
inherent in the adapted criteria used for sepsis classification. One 
example is the criteria based on tachypnea (rate >60 cpm), as most 
neonates born preterm (especially <34 weeks gestation) have some 
degree of respiratory distress syndrome, which can manifest with 
tachypnea in the absence of sepsis. The use of blood culture in the 
sepsis definition in this age group is another limitation because of its 
low sensitivity given the limited volume of blood used for the test. 
  
  
Conclusion 
 
In summary, this study has shown that within the first 12 hours of 
life, PCT is a more reliable acute phase reactant in diagnosing 
neonates with sepsis than CRP. The use of PCT during the first 12 
hours of life may limit number of neonates started on antibiotics due 
to suspected risk of sepsis when there are no strong clinical 
indicators of illness. Limiting unnecessary use of antibiotics in NICUs 
in low-resource settings will improve efficiency in clinical care and 
decrease the rising trend of antimicrobial resistance. 
 
What is known about this topic 
 
The role of PCT and CRP, in the diagnosis of neonatal sepsis remain 
controversial; 
CRP is a valuable screening marker for the diagnosis of neonatal 
sepsis, however, there are variations in levels depending on 
physiological state of neonate (e.g birth weight or gestational age). 
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What this study adds 
 
Within the first 12 hours of life, PCT is a more reliable acute phase 
reactant in diagnosing neonates with sepsis than CRP in this cohort 
of neonates; 
Although PCT has low specificity (relative to CRP), it may improve 
antimicrobial use accountability in low-income countries as clinicians 
would treat fewer newborns without sepsis than current practice 
where most newborns in NICUs are given antibiotics. 
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Table 1: Criteria for classification based on Tollner's sepsis score and case definition of bloodstream 
infection 
I Positive blood culture (pathogenic microorganism) 
II Negative blood culture 
III Maternal risk (prolonged premature rapture of membranes > 18 hours) 
IV Tachycardia (Heart rate > 160 bpm) or Bradycardia  (Heart rate < 100 bpm) 
V Tachypnea (Rate > 60 cpm) 
VI Leukopenia (WBC < 5 x 109/L) or Leukocytosis (WBC > 25 x 109/L) 
VII Thrombocytopenia (platelet < 150 x 109/L) 
Highly probable (Group 1): I or II, plus > 3 of remaining criteria 
Probable (Group 2): II, plus 2 or 3 of remaining criteria (I excluded) 
Less probable (Group 3):  II, plus < 2 of remaining criteria (I excluded) 
  
 
 
Table 2: Characteristics [mean (SD)] of recruited neonates with clinical suspicion of sepsis 
Characteristic 
Highly probable 
(n = 22) 
Probable 
(n = 19) 
Less 
probable 
(n = 21) 
p-value 
Gestational age (wks) 33.2 (4.3) 32.5 (4.2) 34.8 (4.3) 0.2 
Birth weight (kg) 2.1 (0.9) 1.7 (0.7) 2.4 (1.1) 0.08 
Sampling time postnatal 
hours 
  
5.5 (3.3) 
  
4.1 (2.8) 
  
6. (2.2) 
  
0.1 
PCT (ng/mL) 4.2 (2.2) 1.5 (1.2) 0.8 (0.6) <0.001 
CRP (mg/L) 7.4 (13.4) 2.9 (3.9) 1.9 (1.8) 0.08 
  
 
 
Table 3: Selected characteristics of neonates with positive blood culture in the highly probable sepsis group 
  
N 
  
          Isolate 
GA 
(weeks) 
BW 
(kg) 
PNA 
(hours) 
CRP 
(mg/L) 
PCT 
(ng/mL) 
 1  Burkholderia cepacia 26  1.1  1.3  0.6  2.3 
  
2 
 Klebsiella pneumonia 2 26 0.9  1 
  
2.5 
 3.1 
3  Streptococcus viridians 30 1.7 0.9  1.6 8.1 
 4  Escherichia coli  31  1.5 3.2 0.4 1.9 
5  Streptococcus agalactiae 2 33  1.9 0.4  64.5 2.5 
 6  Klebsiella pneumonia 1 33 1.6 0.9 5.2 7.5 
 7  Acinetobacter baumannii  38  3.2 3.3 7.1 3.7 
 8  Streptococcus agalactiae 1 38 3.2  2.3  8.1 4.9 
 GA = Gestational age, BW = Birth weight, PNA = Postnatal age 
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Figure 1: Receiver operator characteristic curves of PCT and CRP 
 
 
 
 
 
 
